expectant management / treatment of prostate cancer / prostate cancer care / treatment of benign prostatic hyperplasia / investigational product / /
MarketIndex
BPH Impact / /
MedicalCondition
low-grade cancer / cancers / localized low risk prostate cancer / tumor / advanced disease / cancer / BPH / tumors / disease / urinary retention / hematuria / prostate cancers / dysfunction / well-differentiated / less aggressive tumors / hematospermia / US prostate cancer / large aggressive tumors / common non-cutaneous cancer / localized prostate cancer / severe symptomatic benign prostatic hyperplasia / costly cancer / benign prostatic hyperplasia / aggressive tumors / biopsy-detectable prostate cancer / urinary tract infections / prostate cancer / bowel dysfunction / low grade cancers / /
MedicalTreatment
radiation therapy / surgeries / prostatectomies / drug therapy / surgery / brachytherapy / radiation / prostate cancer surgeries / /
Organization
National Cancer Institute / National Institute of Health / U.S. Food and Drug Administration / American Cancer Society / International Society of Urological Pathology / /
Avodart Prostate Cancer Risk Reduction Briefing Document